In that study, the authors reported that the upregulation of NAMPT in tubular cells, mediated by increased SIRT1 levels, maintained adequate nicotinamide mononucleotide (NMN) concentrations around glomeruli to promote podocyte function, ultimately translating into an anti-albuminuric effect in diabetes. This evidence concerns the gene NAMPT and diabetes mellitus.